Evidence map›Paper›PMID 32720298›Full record

ArticleJournal of urban health : bulletin of the New York Academy of Medicine2020

A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs.

Robert Heimer, Ryan McNeil, David Vlahov

Abstract read
In one paragraph

Article in Journal of urban health : bulletin of the New York Academy of Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review.Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Review
  16. Article
  17. Opioid Overdose-Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic.Journal of urban health : bulletin of the New York Academy of Medicine · 2020
    Article
  18. Review
  19. COVID-19 and People Who Use Drugs - A Commentary.Health behavior and policy review · 2020
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Robert HeimerDepartment of Epidemiology of Microbial Diseases and the Center for Interdisciplinary Research on AIDS, Yale University School of Public Health, New Haven, CT, USA. robert.heimer@yale.edu.ORCID 0000-0003-0589-6697
Ryan McNeilYale Program on Addiction Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
David VlahovYale University School of Nursing, West Haven, CT, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Effective responses to a global pandemic require local action. In the face of a pandemic or similar emergencies, communities of people who use drugs face risks that result from their ongoing drug use, reduced ability to secure treatment for drug use and correlated maladies, lack of access to preventive hygiene, and the realities of homelessness, street-level policing, and criminal justice involvement. Herein, we document the efforts of a coalition of people who use drugs, advocates, service providers, and academics to implement solutions to reduce these risks at a municipal and state level focusing on New Haven and the State of Connecticut. This coalition identified the communities at risk: active users needing access to harm reduction services, persons in treatment needing access to their medications, the homeless and marginally housed needing improved hygiene, people engaged in sex work, and the incarcerated needing release from custody. The section describing each of the risks demonstrates how the coalition acted preemptively at early stages of the pandemic, ahead of official initiatives, to develop ameliorative risk reduction solutions. Outcomes discussed include instances in which obstacles were overcome or still remain.

Indexed as

BetacoronavirusHuman RightsCoronavirus InfectionsCOVID-19HumansIll-Housed PersonsPandemicsPneumonia, ViralRight to HealthSARS-CoV-2Sex WorkSubstance-Related DisordersCOVID-19Harm reductionHomelessnessIncarcerationPeople who use drugsSubstance abuse disordersTreatment for opioid use disorders

Identifiers

PMID32720298
PMCPMC7384769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.